BioRender Template
PROTAC: Proteolytic Targeting Chimera
Use This Template – Free
No credit card required to sign up.
This template is fully editable in BioRender
- Swap in different text, shapes, & icons
- Recolor and rearrange every icon, line, & label
- Export or share for any use case
Join 4M+ scientists already making publication-ready figures
Description:
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
PROTAC is a progressing technology with a huge scope in protein degradation based therapies for cancer and Alzheimer's like disease. It is a small molecule which has two active domains and a linker. One of the domain binds to the target protein while other one binds to the E3 ligase enzyme, bringing the two proteins in close proximity of each other causing ubiquitination of target protein, followed by its proteasomal degradation. This can allow us to selectively eliminate target proteins.
Updated
August 2026
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Not quite the right template? Discover more.
Search thousands of templates across 30+ life-science fields.
Popular topics:
Cell
Cancer
Drug Delivery
Mechanism of Action
Pathway
Try a synonym, or sign up to suggest a template from the app.
Newest templates
BioRender Template FAQs
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
PROTAC is a progressing technology with a huge scope in protein degradation based therapies for cancer and Alzheimer's like disease. It is a small molecule which has two active domains and a linker. One of the domain binds to the target protein while other one binds to the E3 ligase enzyme, bringing the two proteins in close proximity of each other causing ubiquitination of target protein, followed by its proteasomal degradation. This can allow us to selectively eliminate target proteins.